期刊文献+

Galectin-3蛋白在鼻咽癌组织的表达及其临床意义 被引量:2

The expression of Galectin-3 protein in nasopharyngeal carcinoma and its clinical significance
下载PDF
导出
摘要 目的探讨Galectin-3蛋白在鼻咽癌组织的表达及其临床意义。方法采用免疫组化的方法检测Galectin-3蛋白在94例鼻咽癌和50例慢性鼻咽炎组织中的表达,分析Galectin-3蛋白的表达差异,以及其与临床病理参数和复发转移的关系。结果鼻咽癌患者肿瘤组织中的Galectin-3阳性表达率显著高于慢性鼻咽炎患者的鼻咽组织(60.6%vs 36.0%,χ2=7.939,P=0.005)。T4期患者的Galectin-3阳性表达率显著高于T1期患者(75.0%vs40.0%,χ2=4.778,P=0.029),而Ⅰ期、Ⅱ期、Ⅲ期和Ⅳ期的Galectin-3阳性表达率分别为0、48.3%、61.8%和78.6%(χ2=10.269,P=0.016)。Galectin-3表达阳性的鼻咽癌患者中复发转移率明显高于表达阴性的患者(24.6%vs 5.4%,χ2=5.829,P=0.016)。结论 Galectin-3蛋白与鼻咽癌发生、发展、复发和转移密切相关。 Objective To explore the expression of Galectin-3 protein in nasopharyngeal carcinoma(NPC) and its clinical significance.Methods Galectin-3 protein was detected by immunohistochemistry technique in the tissues of 94 NPC and 50 chronic nasopharyngitis patients.The different expression of Galectin-3 protein and its relationships with clinicopathological parameters,recurrence and metastasis were analyzed.Results The Galectin-3 expression rate in patients with NPC was significantly higher than in patients with chronic nasopharyngitis(60.6% vs 36.0%,χ2=7.939,P=0.005).The Galectin-3 expression rate in stage T4 NPC patients was significantly higher than in stage T1 patients(75.0% vs 40.0%,χ2=4.778,P=0.029),while the Galectin-3 expression rates in stageⅠ,Ⅱ,Ⅲ and Ⅳ patients were 0,48.3%,61.8% and 78.6% respectively(χ2=10.269,P=0.016).The recurrence and metastasis rate in NPC patients with Galectin-3 expression was significantly higher than in patients without Galectin-3 expression(24.6% vs 5.4%,χ2=5.829,P=0.016).Conclusion Galectin-3 protein is closely related with the occurrence,development,recurrence and metastasis of NPC.
出处 《广州医药》 2011年第5期17-19,共3页 Guangzhou Medical Journal
基金 广州市医药卫生科技项目(2009-YB-014)
关键词 GALECTIN-3蛋白 鼻咽癌 免疫组织化学 Galectin-3 protein Nasopharyngeal carcinoma Immunohistochemistry
  • 相关文献

参考文献5

  • 1Krzeslak A, Lipinska A. Galectin-3 as a multifunctional protein [J] . Cell Mol Biol Lett, 2004, 9 (2): 305- 328.
  • 2Nakahara S, Raz A. Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway [ J ] . Cancer Metastasis Rev, 2007, 26 (3-4): 605-610.
  • 3许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 4Honjo Y, Inohara H, Akahani S, et al.. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma [J] . Clin Cancer Res, 2000, 6 (12): 4635- 4640.
  • 5Saussez S, Lorfevre F, Lequeux T, et al. The determina- tion of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progres- sion and/or responses to therapy [ J ] . Oral Oncol, 2008, 44 (1): 86-93.

二级参考文献3

共引文献1367

同被引文献24

  • 1戴嵩玮,王小敏,刘丽云,刘吉福,武珊珊,黄凌云,肖雪媛,何大澄.一个在肺癌血清中高表达的标志分子SAA的发现及鉴定[J].中国科学(C辑),2007,37(2):129-134. 被引量:25
  • 2杨国华,刘海鹰.Galectin-3与肿瘤的研究进展[J].中华肿瘤防治杂志,2007,14(22):1755-1758. 被引量:18
  • 3Canesin G,Gonzalez-Peramato P,Palou J,et al.Galectin-3 expression is associated with bladder cancer progression and clinical outcome[J].Tumour Biol,2010,31(4):277-285.
  • 4Oka N,Nakahara S,Takenaka Y,et al.Galectin-3 inhibits tum or necrosis is factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder careinoma cells[J].Cancer Res,2005,65(17):7546-7553.
  • 5Lagana A,Goetz JG,Cheung P,et al.Galectin binding to Mgat5-modified N-Glycans regulates fibronectin matrix remodeling in tumor cells[J].Mol Cell Biol,2006,26(8):3181-3193.
  • 6Legendre H,Decaestecker C,Nagy N,et al.Prognostic values of galectin-3 and the macrophage migratio ninhibitory factor(MIF)in human coloectal cancers[J].Mod Pathol,2003,16(5):491-504.
  • 7Tsuboi K,Shimura T,Masuda N,et al.Galectin-3 expression in colorectal cancer:relation to invasion andmetastasis[J].Anticancer Res,2007,27(4B):2289-2296.
  • 8Shko TA,Blackwood MA,Schumm PL,et al.Molecu larcytogenetic analysis of Her-2/neu gene in BRCAI-associated breast cancers[J].Cancer Res,2002,62(5):1481-1488.
  • 9Haroah PD,Day NE,Caldas C,et al.Somatic mutation in the p53 gene and prognosis in beast cancer:a meta-analysis[J].I Br J Cancel,1999,80(12):1968-1973.
  • 10Banning M.Advanced breast cancer:aetiology,treatment and psychosocial features[J].Br J Nurs,2007,16(2):86-90.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部